nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Gemcitabine—kidney cancer	0.303	1	CbGbCtD
Emtricitabine—Lamivudine—Gemcitabine—kidney cancer	0.235	0.447	CrCrCtD
Emtricitabine—Zalcitabine—Gemcitabine—kidney cancer	0.203	0.386	CrCrCtD
Emtricitabine—Decitabine—Gemcitabine—kidney cancer	0.0883	0.168	CrCrCtD
Emtricitabine—DCK—Purine salvage—APRT—kidney cancer	0.00426	0.279	CbGpPWpGaD
Emtricitabine—Lamivudine—PGK1—kidney cancer	0.00324	0.955	CrCbGaD
Emtricitabine—DCK—Purine metabolism—PPAT—kidney cancer	0.00218	0.142	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—APRT—kidney cancer	0.00202	0.132	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.00191	0.125	CbGpPWpGaD
Emtricitabine—DCK—Sirolimus—Temsirolimus—kidney cancer	0.00121	0.431	CbGdCrCtD
Emtricitabine—DCK—Sirolimus—Everolimus—kidney cancer	0.00121	0.431	CbGdCrCtD
Emtricitabine—DCK—Nucleotide metabolism—PPAT—kidney cancer	0.00109	0.0716	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—APRT—kidney cancer	0.00102	0.0666	CbGpPWpGaD
Emtricitabine—DCK—Epirubicin—Doxorubicin—kidney cancer	0.000389	0.139	CbGdCrCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000173	0.0113	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000158	0.0104	CbGpPWpGaD
Emtricitabine—Lamivudine—ABCB1—kidney cancer	0.000154	0.0453	CrCbGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.000151	0.00989	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ACY1—kidney cancer	0.000143	0.00938	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PDHB—kidney cancer	0.000122	0.00798	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	0.000121	0.00793	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CCBL1—kidney cancer	0.000115	0.0075	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	9.95e-05	0.00651	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GLIPR1—kidney cancer	9.94e-05	0.0065	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PPAT—kidney cancer	9.94e-05	0.0065	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—APRT—kidney cancer	9.24e-05	0.00605	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—FH—kidney cancer	9.24e-05	0.00605	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GPC3—kidney cancer	8.68e-05	0.00569	CbGpPWpGaD
Emtricitabine—Infection—Vincristine—kidney cancer	8.45e-05	0.000567	CcSEcCtD
Emtricitabine—Urinary tract infection—Capecitabine—kidney cancer	8.45e-05	0.000567	CcSEcCtD
Emtricitabine—DCK—Metabolism—CA2—kidney cancer	8.45e-05	0.00553	CbGpPWpGaD
Emtricitabine—Arthralgia—Gemcitabine—kidney cancer	8.42e-05	0.000565	CcSEcCtD
Emtricitabine—Myalgia—Gemcitabine—kidney cancer	8.42e-05	0.000565	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	8.36e-05	0.000561	CcSEcCtD
Emtricitabine—Nervous system disorder—Vincristine—kidney cancer	8.34e-05	0.00056	CcSEcCtD
Emtricitabine—Asthenia—Erlotinib—kidney cancer	8.34e-05	0.000559	CcSEcCtD
Emtricitabine—Mental disorder—Paclitaxel—kidney cancer	8.33e-05	0.000559	CcSEcCtD
Emtricitabine—Thrombocytopenia—Vincristine—kidney cancer	8.33e-05	0.000559	CcSEcCtD
Emtricitabine—Urticaria—Sorafenib—kidney cancer	8.3e-05	0.000557	CcSEcCtD
Emtricitabine—Haematuria—Capecitabine—kidney cancer	8.29e-05	0.000556	CcSEcCtD
Emtricitabine—Malnutrition—Paclitaxel—kidney cancer	8.28e-05	0.000556	CcSEcCtD
Emtricitabine—Diarrhoea—Vinblastine—kidney cancer	8.27e-05	0.000555	CcSEcCtD
Emtricitabine—Abdominal pain—Sorafenib—kidney cancer	8.26e-05	0.000554	CcSEcCtD
Emtricitabine—Body temperature increased—Sorafenib—kidney cancer	8.26e-05	0.000554	CcSEcCtD
Emtricitabine—Diarrhoea—Everolimus—kidney cancer	8.24e-05	0.000553	CcSEcCtD
Emtricitabine—DCK—Metabolism—ALAD—kidney cancer	8.23e-05	0.00539	CbGpPWpGaD
Emtricitabine—Gastrointestinal pain—Sunitinib—kidney cancer	8.22e-05	0.000552	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Capecitabine—kidney cancer	8.22e-05	0.000552	CcSEcCtD
Emtricitabine—Pruritus—Erlotinib—kidney cancer	8.22e-05	0.000552	CcSEcCtD
Emtricitabine—Fatigue—Dactinomycin—kidney cancer	8.21e-05	0.000551	CcSEcCtD
Emtricitabine—Pain—Dactinomycin—kidney cancer	8.14e-05	0.000546	CcSEcCtD
Emtricitabine—DCK—Metabolism—ST3GAL2—kidney cancer	8.04e-05	0.00526	CbGpPWpGaD
Emtricitabine—Infection—Gemcitabine—kidney cancer	8.02e-05	0.000538	CcSEcCtD
Emtricitabine—Back pain—Paclitaxel—kidney cancer	8.01e-05	0.000537	CcSEcCtD
Emtricitabine—Dizziness—Vinblastine—kidney cancer	7.99e-05	0.000536	CcSEcCtD
Emtricitabine—Dizziness—Everolimus—kidney cancer	7.96e-05	0.000534	CcSEcCtD
Emtricitabine—Abdominal pain—Sunitinib—kidney cancer	7.95e-05	0.000534	CcSEcCtD
Emtricitabine—Body temperature increased—Sunitinib—kidney cancer	7.95e-05	0.000534	CcSEcCtD
Emtricitabine—Diarrhoea—Erlotinib—kidney cancer	7.95e-05	0.000533	CcSEcCtD
Emtricitabine—Nervous system disorder—Gemcitabine—kidney cancer	7.91e-05	0.000531	CcSEcCtD
Emtricitabine—Thrombocytopenia—Gemcitabine—kidney cancer	7.9e-05	0.00053	CcSEcCtD
Emtricitabine—Renal failure acute—Doxorubicin—kidney cancer	7.88e-05	0.000529	CcSEcCtD
Emtricitabine—DCK—Metabolism—ALDH1A1—kidney cancer	7.85e-05	0.00514	CbGpPWpGaD
Emtricitabine—Skin disorder—Gemcitabine—kidney cancer	7.84e-05	0.000526	CcSEcCtD
Emtricitabine—Rhinitis—Capecitabine—kidney cancer	7.82e-05	0.000525	CcSEcCtD
Emtricitabine—Hepatitis—Capecitabine—kidney cancer	7.8e-05	0.000524	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dactinomycin—kidney cancer	7.79e-05	0.000522	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Vincristine—kidney cancer	7.75e-05	0.00052	CcSEcCtD
Emtricitabine—Pharyngitis—Capecitabine—kidney cancer	7.75e-05	0.00052	CcSEcCtD
Emtricitabine—Urinary tract disorder—Capecitabine—kidney cancer	7.71e-05	0.000517	CcSEcCtD
Emtricitabine—Hypersensitivity—Sorafenib—kidney cancer	7.7e-05	0.000517	CcSEcCtD
Emtricitabine—Insomnia—Vincristine—kidney cancer	7.69e-05	0.000516	CcSEcCtD
Emtricitabine—Vomiting—Vinblastine—kidney cancer	7.69e-05	0.000516	CcSEcCtD
Emtricitabine—Dizziness—Erlotinib—kidney cancer	7.68e-05	0.000516	CcSEcCtD
Emtricitabine—Connective tissue disorder—Capecitabine—kidney cancer	7.67e-05	0.000515	CcSEcCtD
Emtricitabine—Vomiting—Everolimus—kidney cancer	7.66e-05	0.000514	CcSEcCtD
Emtricitabine—Anaemia—Paclitaxel—kidney cancer	7.65e-05	0.000513	CcSEcCtD
Emtricitabine—Urethral disorder—Capecitabine—kidney cancer	7.65e-05	0.000513	CcSEcCtD
Emtricitabine—Renal impairment—Doxorubicin—kidney cancer	7.64e-05	0.000513	CcSEcCtD
Emtricitabine—Paraesthesia—Vincristine—kidney cancer	7.64e-05	0.000513	CcSEcCtD
Emtricitabine—Dermatitis bullous—Doxorubicin—kidney cancer	7.61e-05	0.000511	CcSEcCtD
Emtricitabine—Rash—Everolimus—kidney cancer	7.59e-05	0.000509	CcSEcCtD
Emtricitabine—Dermatitis—Everolimus—kidney cancer	7.58e-05	0.000509	CcSEcCtD
Emtricitabine—Headache—Vinblastine—kidney cancer	7.57e-05	0.000508	CcSEcCtD
Emtricitabine—Angioedema—Paclitaxel—kidney cancer	7.56e-05	0.000508	CcSEcCtD
Emtricitabine—Headache—Everolimus—kidney cancer	7.54e-05	0.000506	CcSEcCtD
Emtricitabine—DCK—Metabolism—SLC5A3—kidney cancer	7.53e-05	0.00493	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PGK1—kidney cancer	7.53e-05	0.00493	CbGpPWpGaD
Emtricitabine—Abdominal pain—Dactinomycin—kidney cancer	7.53e-05	0.000505	CcSEcCtD
Emtricitabine—Body temperature increased—Dactinomycin—kidney cancer	7.53e-05	0.000505	CcSEcCtD
Emtricitabine—Asthenia—Sorafenib—kidney cancer	7.5e-05	0.000503	CcSEcCtD
Emtricitabine—Hypersensitivity—Sunitinib—kidney cancer	7.41e-05	0.000497	CcSEcCtD
Emtricitabine—Pruritus—Sorafenib—kidney cancer	7.39e-05	0.000496	CcSEcCtD
Emtricitabine—Vomiting—Erlotinib—kidney cancer	7.39e-05	0.000496	CcSEcCtD
Emtricitabine—DCK—Metabolism—LDHB—kidney cancer	7.38e-05	0.00483	CbGpPWpGaD
Emtricitabine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	7.35e-05	0.000493	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Vincristine—kidney cancer	7.34e-05	0.000493	CcSEcCtD
Emtricitabine—Fatigue—Vincristine—kidney cancer	7.33e-05	0.000492	CcSEcCtD
Emtricitabine—Rash—Erlotinib—kidney cancer	7.33e-05	0.000492	CcSEcCtD
Emtricitabine—Dermatitis—Erlotinib—kidney cancer	7.32e-05	0.000491	CcSEcCtD
Emtricitabine—Insomnia—Gemcitabine—kidney cancer	7.3e-05	0.00049	CcSEcCtD
Emtricitabine—Headache—Erlotinib—kidney cancer	7.28e-05	0.000488	CcSEcCtD
Emtricitabine—Pain—Vincristine—kidney cancer	7.27e-05	0.000488	CcSEcCtD
Emtricitabine—Paraesthesia—Gemcitabine—kidney cancer	7.25e-05	0.000486	CcSEcCtD
Emtricitabine—Cough—Paclitaxel—kidney cancer	7.22e-05	0.000485	CcSEcCtD
Emtricitabine—Asthenia—Sunitinib—kidney cancer	7.22e-05	0.000484	CcSEcCtD
Emtricitabine—Dyspnoea—Gemcitabine—kidney cancer	7.19e-05	0.000483	CcSEcCtD
Emtricitabine—Nausea—Vinblastine—kidney cancer	7.18e-05	0.000482	CcSEcCtD
Emtricitabine—Nausea—Everolimus—kidney cancer	7.15e-05	0.00048	CcSEcCtD
Emtricitabine—Diarrhoea—Sorafenib—kidney cancer	7.15e-05	0.00048	CcSEcCtD
Emtricitabine—Pruritus—Sunitinib—kidney cancer	7.12e-05	0.000478	CcSEcCtD
Emtricitabine—Immune system disorder—Capecitabine—kidney cancer	7.05e-05	0.000473	CcSEcCtD
Emtricitabine—Arthralgia—Paclitaxel—kidney cancer	7.05e-05	0.000473	CcSEcCtD
Emtricitabine—Myalgia—Paclitaxel—kidney cancer	7.05e-05	0.000473	CcSEcCtD
Emtricitabine—Mediastinal disorder—Capecitabine—kidney cancer	7.03e-05	0.000472	CcSEcCtD
Emtricitabine—Anxiety—Paclitaxel—kidney cancer	7.02e-05	0.000471	CcSEcCtD
Emtricitabine—Hypersensitivity—Dactinomycin—kidney cancer	7.01e-05	0.000471	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	7e-05	0.00047	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Gemcitabine—kidney cancer	6.97e-05	0.000468	CcSEcCtD
Emtricitabine—Fatigue—Gemcitabine—kidney cancer	6.96e-05	0.000467	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Vincristine—kidney cancer	6.96e-05	0.000467	CcSEcCtD
Emtricitabine—Dizziness—Sorafenib—kidney cancer	6.91e-05	0.000464	CcSEcCtD
Emtricitabine—Pain—Gemcitabine—kidney cancer	6.9e-05	0.000463	CcSEcCtD
Emtricitabine—Nausea—Erlotinib—kidney cancer	6.9e-05	0.000463	CcSEcCtD
Emtricitabine—Diarrhoea—Sunitinib—kidney cancer	6.88e-05	0.000462	CcSEcCtD
Emtricitabine—Mental disorder—Capecitabine—kidney cancer	6.84e-05	0.000459	CcSEcCtD
Emtricitabine—Asthenia—Dactinomycin—kidney cancer	6.83e-05	0.000458	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—kidney cancer	6.81e-05	0.000457	CcSEcCtD
Emtricitabine—Malnutrition—Capecitabine—kidney cancer	6.79e-05	0.000456	CcSEcCtD
Emtricitabine—Body temperature increased—Vincristine—kidney cancer	6.72e-05	0.000451	CcSEcCtD
Emtricitabine—Abdominal pain—Vincristine—kidney cancer	6.72e-05	0.000451	CcSEcCtD
Emtricitabine—Infection—Paclitaxel—kidney cancer	6.71e-05	0.00045	CcSEcCtD
Emtricitabine—Dizziness—Sunitinib—kidney cancer	6.65e-05	0.000446	CcSEcCtD
Emtricitabine—Vomiting—Sorafenib—kidney cancer	6.65e-05	0.000446	CcSEcCtD
Emtricitabine—Nervous system disorder—Paclitaxel—kidney cancer	6.63e-05	0.000445	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—kidney cancer	6.62e-05	0.000444	CcSEcCtD
Emtricitabine—Thrombocytopenia—Paclitaxel—kidney cancer	6.62e-05	0.000444	CcSEcCtD
Emtricitabine—Rash—Sorafenib—kidney cancer	6.59e-05	0.000442	CcSEcCtD
Emtricitabine—Dermatitis—Sorafenib—kidney cancer	6.58e-05	0.000442	CcSEcCtD
Emtricitabine—Back pain—Capecitabine—kidney cancer	6.57e-05	0.000441	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—kidney cancer	6.57e-05	0.000441	CcSEcCtD
Emtricitabine—Skin disorder—Paclitaxel—kidney cancer	6.56e-05	0.00044	CcSEcCtD
Emtricitabine—Headache—Sorafenib—kidney cancer	6.55e-05	0.000439	CcSEcCtD
Emtricitabine—Diarrhoea—Dactinomycin—kidney cancer	6.51e-05	0.000437	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—kidney cancer	6.5e-05	0.000436	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.41e-05	0.00043	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—kidney cancer	6.41e-05	0.00043	CcSEcCtD
Emtricitabine—DCK—Metabolism—CA9—kidney cancer	6.4e-05	0.00419	CbGpPWpGaD
Emtricitabine—Vomiting—Sunitinib—kidney cancer	6.39e-05	0.000429	CcSEcCtD
Emtricitabine—Body temperature increased—Gemcitabine—kidney cancer	6.38e-05	0.000428	CcSEcCtD
Emtricitabine—Rash—Sunitinib—kidney cancer	6.34e-05	0.000426	CcSEcCtD
Emtricitabine—Dermatitis—Sunitinib—kidney cancer	6.34e-05	0.000425	CcSEcCtD
Emtricitabine—Headache—Sunitinib—kidney cancer	6.3e-05	0.000423	CcSEcCtD
Emtricitabine—Anaemia—Capecitabine—kidney cancer	6.28e-05	0.000421	CcSEcCtD
Emtricitabine—Hypersensitivity—Vincristine—kidney cancer	6.27e-05	0.000421	CcSEcCtD
Emtricitabine—Nausea—Sorafenib—kidney cancer	6.21e-05	0.000417	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—kidney cancer	6.16e-05	0.000414	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.16e-05	0.000413	CcSEcCtD
Emtricitabine—Insomnia—Paclitaxel—kidney cancer	6.11e-05	0.00041	CcSEcCtD
Emtricitabine—Asthenia—Vincristine—kidney cancer	6.1e-05	0.00041	CcSEcCtD
Emtricitabine—Paraesthesia—Paclitaxel—kidney cancer	6.07e-05	0.000407	CcSEcCtD
Emtricitabine—Vomiting—Dactinomycin—kidney cancer	6.05e-05	0.000406	CcSEcCtD
Emtricitabine—Dyspnoea—Paclitaxel—kidney cancer	6.02e-05	0.000404	CcSEcCtD
Emtricitabine—Rash—Dactinomycin—kidney cancer	6e-05	0.000403	CcSEcCtD
Emtricitabine—Nausea—Sunitinib—kidney cancer	5.97e-05	0.000401	CcSEcCtD
Emtricitabine—Dyspepsia—Paclitaxel—kidney cancer	5.95e-05	0.000399	CcSEcCtD
Emtricitabine—Cough—Capecitabine—kidney cancer	5.93e-05	0.000398	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—kidney cancer	5.88e-05	0.000394	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—kidney cancer	5.84e-05	0.000392	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.83e-05	0.000391	CcSEcCtD
Emtricitabine—Fatigue—Paclitaxel—kidney cancer	5.82e-05	0.000391	CcSEcCtD
Emtricitabine—Diarrhoea—Vincristine—kidney cancer	5.82e-05	0.000391	CcSEcCtD
Emtricitabine—Asthenia—Gemcitabine—kidney cancer	5.79e-05	0.000389	CcSEcCtD
Emtricitabine—Myalgia—Capecitabine—kidney cancer	5.78e-05	0.000388	CcSEcCtD
Emtricitabine—Arthralgia—Capecitabine—kidney cancer	5.78e-05	0.000388	CcSEcCtD
Emtricitabine—Pain—Paclitaxel—kidney cancer	5.78e-05	0.000388	CcSEcCtD
Emtricitabine—Anxiety—Capecitabine—kidney cancer	5.76e-05	0.000387	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.74e-05	0.000385	CcSEcCtD
Emtricitabine—Pruritus—Gemcitabine—kidney cancer	5.71e-05	0.000383	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—kidney cancer	5.69e-05	0.000382	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—kidney cancer	5.67e-05	0.00038	CcSEcCtD
Emtricitabine—Nausea—Dactinomycin—kidney cancer	5.66e-05	0.00038	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—kidney cancer	5.64e-05	0.000378	CcSEcCtD
Emtricitabine—Dizziness—Vincristine—kidney cancer	5.63e-05	0.000378	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—kidney cancer	5.6e-05	0.000376	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—kidney cancer	5.6e-05	0.000376	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Paclitaxel—kidney cancer	5.52e-05	0.000371	CcSEcCtD
Emtricitabine—Diarrhoea—Gemcitabine—kidney cancer	5.52e-05	0.000371	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—kidney cancer	5.51e-05	0.00037	CcSEcCtD
Emtricitabine—Infection—Capecitabine—kidney cancer	5.51e-05	0.00037	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—kidney cancer	5.49e-05	0.000369	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—kidney cancer	5.45e-05	0.000366	CcSEcCtD
Emtricitabine—DCK—Metabolism—CRABP1—kidney cancer	5.44e-05	0.00356	CbGpPWpGaD
Emtricitabine—Nervous system disorder—Capecitabine—kidney cancer	5.44e-05	0.000365	CcSEcCtD
Emtricitabine—Thrombocytopenia—Capecitabine—kidney cancer	5.43e-05	0.000364	CcSEcCtD
Emtricitabine—Vomiting—Vincristine—kidney cancer	5.41e-05	0.000363	CcSEcCtD
Emtricitabine—Skin disorder—Capecitabine—kidney cancer	5.39e-05	0.000361	CcSEcCtD
Emtricitabine—Urticaria—Paclitaxel—kidney cancer	5.37e-05	0.00036	CcSEcCtD
Emtricitabine—Rash—Vincristine—kidney cancer	5.36e-05	0.00036	CcSEcCtD
Emtricitabine—Dermatitis—Vincristine—kidney cancer	5.36e-05	0.00036	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—kidney cancer	5.34e-05	0.000359	CcSEcCtD
Emtricitabine—Abdominal pain—Paclitaxel—kidney cancer	5.34e-05	0.000358	CcSEcCtD
Emtricitabine—Body temperature increased—Paclitaxel—kidney cancer	5.34e-05	0.000358	CcSEcCtD
Emtricitabine—Headache—Vincristine—kidney cancer	5.33e-05	0.000358	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—kidney cancer	5.3e-05	0.000356	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—kidney cancer	5.26e-05	0.000353	CcSEcCtD
Emtricitabine—Vomiting—Gemcitabine—kidney cancer	5.13e-05	0.000344	CcSEcCtD
Emtricitabine—Rash—Gemcitabine—kidney cancer	5.09e-05	0.000341	CcSEcCtD
Emtricitabine—Dermatitis—Gemcitabine—kidney cancer	5.08e-05	0.000341	CcSEcCtD
Emtricitabine—DCK—Metabolism—ITPR2—kidney cancer	5.06e-05	0.00331	CbGpPWpGaD
Emtricitabine—Headache—Gemcitabine—kidney cancer	5.06e-05	0.000339	CcSEcCtD
Emtricitabine—Nausea—Vincristine—kidney cancer	5.05e-05	0.000339	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.05e-05	0.000339	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—kidney cancer	5.04e-05	0.000338	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—kidney cancer	5.03e-05	0.000338	CcSEcCtD
Emtricitabine—Insomnia—Capecitabine—kidney cancer	5.01e-05	0.000337	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—kidney cancer	4.99e-05	0.000335	CcSEcCtD
Emtricitabine—Paraesthesia—Capecitabine—kidney cancer	4.98e-05	0.000334	CcSEcCtD
Emtricitabine—Hypersensitivity—Paclitaxel—kidney cancer	4.98e-05	0.000334	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—kidney cancer	4.97e-05	0.000333	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—kidney cancer	4.94e-05	0.000332	CcSEcCtD
Emtricitabine—Dyspnoea—Capecitabine—kidney cancer	4.94e-05	0.000332	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—kidney cancer	4.93e-05	0.000331	CcSEcCtD
Emtricitabine—Dyspepsia—Capecitabine—kidney cancer	4.88e-05	0.000328	CcSEcCtD
Emtricitabine—Asthenia—Paclitaxel—kidney cancer	4.85e-05	0.000325	CcSEcCtD
Emtricitabine—Nausea—Gemcitabine—kidney cancer	4.79e-05	0.000322	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Capecitabine—kidney cancer	4.79e-05	0.000321	CcSEcCtD
Emtricitabine—Fatigue—Capecitabine—kidney cancer	4.78e-05	0.000321	CcSEcCtD
Emtricitabine—Pruritus—Paclitaxel—kidney cancer	4.78e-05	0.000321	CcSEcCtD
Emtricitabine—Pain—Capecitabine—kidney cancer	4.74e-05	0.000318	CcSEcCtD
Emtricitabine—Diarrhoea—Paclitaxel—kidney cancer	4.62e-05	0.00031	CcSEcCtD
Emtricitabine—DCK—Metabolism—ACHE—kidney cancer	4.62e-05	0.00302	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTT1—kidney cancer	4.62e-05	0.00302	CbGpPWpGaD
Emtricitabine—Immune system disorder—Doxorubicin—kidney cancer	4.54e-05	0.000305	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Capecitabine—kidney cancer	4.53e-05	0.000304	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—kidney cancer	4.53e-05	0.000304	CcSEcCtD
Emtricitabine—Dizziness—Paclitaxel—kidney cancer	4.47e-05	0.0003	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—kidney cancer	4.41e-05	0.000296	CcSEcCtD
Emtricitabine—Urticaria—Capecitabine—kidney cancer	4.4e-05	0.000296	CcSEcCtD
Emtricitabine—Body temperature increased—Capecitabine—kidney cancer	4.38e-05	0.000294	CcSEcCtD
Emtricitabine—Abdominal pain—Capecitabine—kidney cancer	4.38e-05	0.000294	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—kidney cancer	4.38e-05	0.000294	CcSEcCtD
Emtricitabine—DCK—Metabolism—SCARB1—kidney cancer	4.37e-05	0.00286	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PTGS1—kidney cancer	4.32e-05	0.00283	CbGpPWpGaD
Emtricitabine—Vomiting—Paclitaxel—kidney cancer	4.3e-05	0.000288	CcSEcCtD
Emtricitabine—Rash—Paclitaxel—kidney cancer	4.26e-05	0.000286	CcSEcCtD
Emtricitabine—Dermatitis—Paclitaxel—kidney cancer	4.26e-05	0.000286	CcSEcCtD
Emtricitabine—DCK—Metabolism—PSMD7—kidney cancer	4.24e-05	0.00278	CbGpPWpGaD
Emtricitabine—Back pain—Doxorubicin—kidney cancer	4.24e-05	0.000284	CcSEcCtD
Emtricitabine—Headache—Paclitaxel—kidney cancer	4.23e-05	0.000284	CcSEcCtD
Emtricitabine—Hypersensitivity—Capecitabine—kidney cancer	4.08e-05	0.000274	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—kidney cancer	4.05e-05	0.000272	CcSEcCtD
Emtricitabine—DCK—Metabolism—BCHE—kidney cancer	4.02e-05	0.00263	CbGpPWpGaD
Emtricitabine—Nausea—Paclitaxel—kidney cancer	4.01e-05	0.000269	CcSEcCtD
Emtricitabine—Asthenia—Capecitabine—kidney cancer	3.98e-05	0.000267	CcSEcCtD
Emtricitabine—DCK—Metabolism—SLC5A5—kidney cancer	3.97e-05	0.0026	CbGpPWpGaD
Emtricitabine—Pruritus—Capecitabine—kidney cancer	3.92e-05	0.000263	CcSEcCtD
Emtricitabine—DCK—Metabolism—SLC2A1—kidney cancer	3.84e-05	0.00251	CbGpPWpGaD
Emtricitabine—Cough—Doxorubicin—kidney cancer	3.82e-05	0.000256	CcSEcCtD
Emtricitabine—Diarrhoea—Capecitabine—kidney cancer	3.79e-05	0.000255	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—kidney cancer	3.73e-05	0.00025	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—kidney cancer	3.73e-05	0.00025	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—kidney cancer	3.72e-05	0.000249	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.7e-05	0.000248	CcSEcCtD
Emtricitabine—Dizziness—Capecitabine—kidney cancer	3.67e-05	0.000246	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—kidney cancer	3.55e-05	0.000238	CcSEcCtD
Emtricitabine—Vomiting—Capecitabine—kidney cancer	3.53e-05	0.000237	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—kidney cancer	3.5e-05	0.000235	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—kidney cancer	3.5e-05	0.000235	CcSEcCtD
Emtricitabine—Rash—Capecitabine—kidney cancer	3.5e-05	0.000235	CcSEcCtD
Emtricitabine—Dermatitis—Capecitabine—kidney cancer	3.49e-05	0.000234	CcSEcCtD
Emtricitabine—Headache—Capecitabine—kidney cancer	3.47e-05	0.000233	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—kidney cancer	3.47e-05	0.000233	CcSEcCtD
Emtricitabine—Nausea—Capecitabine—kidney cancer	3.29e-05	0.000221	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.26e-05	0.000219	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—kidney cancer	3.23e-05	0.000217	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—kidney cancer	3.21e-05	0.000215	CcSEcCtD
Emtricitabine—DCK—Metabolism—GSTP1—kidney cancer	3.2e-05	0.00209	CbGpPWpGaD
Emtricitabine—Dyspnoea—Doxorubicin—kidney cancer	3.19e-05	0.000214	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—kidney cancer	3.15e-05	0.000211	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.09e-05	0.000207	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—kidney cancer	3.08e-05	0.000207	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—kidney cancer	3.06e-05	0.000205	CcSEcCtD
Emtricitabine—DCK—Metabolism—ABCB1—kidney cancer	3.03e-05	0.00198	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTM1—kidney cancer	2.94e-05	0.00192	CbGpPWpGaD
Emtricitabine—Gastrointestinal pain—Doxorubicin—kidney cancer	2.92e-05	0.000196	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—kidney cancer	2.84e-05	0.000191	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—kidney cancer	2.83e-05	0.00019	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—kidney cancer	2.83e-05	0.00019	CcSEcCtD
Emtricitabine—DCK—Metabolism—CYP1A1—kidney cancer	2.79e-05	0.00182	CbGpPWpGaD
Emtricitabine—Hypersensitivity—Doxorubicin—kidney cancer	2.63e-05	0.000177	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—kidney cancer	2.56e-05	0.000172	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—kidney cancer	2.53e-05	0.00017	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—kidney cancer	2.45e-05	0.000164	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—kidney cancer	2.36e-05	0.000159	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—kidney cancer	2.27e-05	0.000153	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—kidney cancer	2.25e-05	0.000151	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—kidney cancer	2.25e-05	0.000151	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—kidney cancer	2.24e-05	0.00015	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—kidney cancer	2.12e-05	0.000142	CcSEcCtD
Emtricitabine—DCK—Metabolism—POMC—kidney cancer	2.08e-05	0.00136	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PTGS2—kidney cancer	1.66e-05	0.00109	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PTEN—kidney cancer	1.45e-05	0.000946	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PIK3CA—kidney cancer	1.02e-05	0.000668	CbGpPWpGaD
